Deep learning–enabled discovery of antibiotics effective against Neisseria gonorrhoeae
Science Translational Medicine · 17.06.2026 · 18 (854)
DOI: 10.1126/scitranslmed.ads4699 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Translational Medicine, erschienen am 17.06.2026. Verfasst von Melis N Anahtar und 24 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA. Hauptthemen laut MEDLINE: Neisseria gonorrhoeae, Deep Learning, Anti-Bacterial Agents, Drug Discovery. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, National Institutes of Health, Defense Threat Reduction Agency.
Abstract (Originalsprache)
Neisseria gonorrhoeae is a common Gram-negative pathogen with increasing resistance to all recommended antibiotics. There is a critical need to improve the efficiency of the antibiotic hit discovery process to replenish the drug development pipeline. Here, we show that deep learning models can augment high-throughput screens to identify readily available molecules with narrow-spectrum activity against difficult-to-treat strains of N. gonorrhoeae . We phenotypically tested 38,650 small molecules for N. gonorrhoeae growth inhibition to train a predictive graph neural network (GNN) model. We benchmarked the model’s performance against other architectures, including a large language model, and found that GNNs more accurately identify active, drug-like molecules that are structurally distinct from the training set and known antibiotics. Using the model to virtually screen ~6 million compounds, we identified 213 compounds for experimental validation and found that 83 (39%) inhibited N. gonorrhoeae growth. Two of these compounds were structurally dissimilar to existing antibiotics, maintained potency against multidrug-resistant N. gonorrhoeae strains in vitro, exhibited promising selectivity indices, and were rapidly bactericidal with low frequencies of resistance. Proteomic studies revealed their distinct mechanisms of action, with one compound targeting alanine racemase, an enzyme involved in the essential process of peptidoglycan synthesis. Furthermore, the compounds showed early promise in reducing N. gonorrhoeae titers in a human vagina-on-a-chip infection model and a mouse vaginal infection model. Our work establishes the deep learning–enabled discovery of selective antibacterial compounds against N. gonorrhoeae as a much-needed hit discovery tool to address the growing crisis of antimicrobial resistance for this pathogen.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Infectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
- Departments of Pathology and Medicine, Massachusetts General Hospital, Boston, MA 02114, USA.
- Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA 02215, USA.
- Institute for Medical Engineering and Science and Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
- Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
- Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, MA 02115, USA.
ORCID-Profile: Melis N Anahtar, Jacqueline A Valeri, Seyed Majed Modaresi, Aarti Krishnan, Nina M Donghia, Samantha G Palace, Aakanksha Gulati, Abidemi Junaid, Parijat Bandyopadhyay, Andreas Luttens, Paige Edwards, Felix Wong, Yu Zhang, Danilo Ritz, Margaux Gaborieau, Edmund Loh, Massimiliano Gaetani, Marie-Stephanie Aschtgen, Yonatan H Grad, Donald E Ingber, James J Collins
Förderung
- NIAID NIH HHS
- National Institutes of Health
- Defense Threat Reduction Agency
- Siebel Scholars Foundation
- Novo Nordisk Fonden
- Bill and Melinda Gates Foundation
- Swiss National Science Foundation
- Swedish Research Council
Zitieren
APA
Anahtar, M. N., Valeri, J. A., Modaresi, S. M., Krishnan, A., Donghia, N. M., Palace, S. G., Zheng, E. J., Gulati, A., Jorgenson, A., Junaid, A., Bandyopadhyay, P., Luttens, A., Suresh, K., Edwards, P., Wong, F., Zhang, Y., Ritz, D., Gaborieau, M., Loh, E., …, & Collins, J. J. (2026). Deep learning–enabled discovery of antibiotics effective against Neisseria gonorrhoeae. Science Translational Medicine, 18(854). https://doi.org/10.1126/scitranslmed.ads4699
Vancouver
Anahtar MN, Valeri JA, Modaresi SM, Krishnan A, Donghia NM, Palace SG, et al. Deep learning–enabled discovery of antibiotics effective against Neisseria gonorrhoeae. Science Translational Medicine. 2026;18(854). doi:10.1126/scitranslmed.ads4699
BibTeX
@article{Anahtar2026,
author = {Anahtar, Melis N and Valeri, Jacqueline A and Modaresi, Seyed Majed and Krishnan, Aarti and Donghia, Nina M and Palace, Samantha G and Zheng, Erica J and Gulati, Aakanksha and Jorgenson, Alicia and Junaid, Abidemi and Bandyopadhyay, Parijat and Luttens, Andreas and Suresh, Krishna and Edwards, Paige and Wong, Felix and Zhang, Yu and Ritz, Danilo and Gaborieau, Margaux and Loh, Edmund and Gaetani, Massimiliano and Aschtgen, Marie-Stephanie and Saei, Amir Ata and Grad, Yonatan H and Ingber, Donald E and Collins, James J},
title = {Deep learning–enabled discovery of antibiotics effective against Neisseria gonorrhoeae},
journal = {Science Translational Medicine},
year = {2026},
volume = {18},
number = {854},
doi = {10.1126/scitranslmed.ads4699}
}
EUVIMED